Videos

HMO Mechanisms of Action

Publication Date: 09 May 2017

Presenter(s): Philip C.Calder,PhD, Ardythe L.Morrow,PhD, Christina E.West, MD,PhD, Richard D.Cummings,PhD

Location: Prague, Czech Republic

Human milk oligosaccharides (HMOs) are the third most abundant solid component of human milk. In the infant gut, HMOs serve as prebiotics to promote the growth of beneficial bacteria and antiadhesives to limit colonization of pathogenic bacteria.

Presenter Bio(s):

Philip C. Calder, PhD

University of Southampton
Southampton, England, UK

Ardythe I. Morrow, PhD

University of Cincinnati; Cincinnati, Ohio, USA

Christina E. West, MD, PhD

Umeå University; Umeå, Sweden

Richard D. Cummings, PhD

Harvard Medical School; Boston, Massachusetts, USA

Category